Sign inGet started

Drygin Denis

Insider CIK 1819692 · RGLS Chief Scientific Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RGLS Regulus Therapeutics Inc. P Buy2022-03-012022-03-0176,686$0.23 $17.6K100,000SEC↗
RGLS Regulus Therapeutics Inc. P Buy2022-02-042022-02-0723,314$0.23 $5.4K23,314SEC↗
RGLS Regulus Therapeutics Inc. A Award deriv2022-01-122022-01-26400,000— $0400,000SEC↗
RGLS Regulus Therapeutics Inc. A Award deriv2021-02-042021-02-05120,000— $0120,000SEC↗
RGLS Regulus Therapeutics Inc. A Award deriv2020-03-032020-08-05300,000— $0300,000SEC↗